Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is a clinical trial sponsor. It has 68 active clinical trials with 15,939 planned participants, across 15 therapeutic areas. Since 2021 it has completed 48 trials and stopped 29 early.
Trial track record · since 2021
Pipeline · 68 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Chia Tai Tianqing Pharmaceutical Group Co., Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd is lead sponsor of 68 active clinical trials on ClinicalTrials.gov, with 15,939 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 48 trials and stopped 29 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-20.
Approve Suite is not affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.